U.S.A. researches and develops a and resists the new medicine of influenza

U.S.A. researches and develops a and resists the new medicine of influenza
San Francisco, September 13 (Xinhuanet) a biological drugmaker in U.S.A. announces on the 13th, they develop a new medicine, are found it is effective to popular first type H1N1 influenza virus at present by animal's experiment test, and because it does not act on the virus directly, it is able to bear the nature question not to present the virus easily.Say at resisting little biologic product and chemotherapy meeting in U.S.A. which U.S.A. NexBio biological drugmaker holds in San Francisco on the 13th, the new medicine of test which they researched and developed " Influenza and enzyme " ( Fludase) Having made good curative effect on experiment mouse, the first type H1N1 influenza prevailing as to ordinary seasonal influenza and at present is effective.
And then, they will also carry on the relevant clinical trial.Different from reaching the neural amino acid enzyme inhibitor medicine in Philippines,etc., " influenza and enzyme " Principal ingredients for saliva enzymes sour merge for albumen. It cell in target of function, make the intersection of constellation and the intersection of chief cell and saliva sour receptor of surface lose activity, influenza virus is unable to bind with receptor, it is just unable to adhere to cells. And the principle of reaching Philippine,etc. medicine is to inhibit neural amino acid enzyme in surface of influenza virus, make it unable to infect cells, so the virus is apt to morph to emerge and is able to bear nature.NexBio Company says in the press Communique released on the same day, " influenza and enzyme " Have not demonstrated any obvious drug resistance under test. In addition, as to already producing poisonous one of influenza virus able to bear nature in reaching the Philippine medicine, " influenza and enzyme " Also can resist it and invade cells.Influenza virus in the course of propagating apt to become, confront with each other virus medicines, produce and is able to bear nature variable in most old characteristic. First type the intersection of H1N1 and influenza virus a plurality of country travel in world at present, use to up to Philippines, treat Company, Luo of Switzerland, usually in being clinical. But according to Luo's newest statistics, the whole world has already reported 23 produce the first type H1N1 influenza case able to bear nature in reaching Philippines.
|